Regulation/NN
of/IN
gene/NN
expression/NN
with/IN
double-stranded/JJ
phosphorothioate/NN
oligonucleotides/NNS
./.

Alteration/NN
of/IN
gene/NN
transcription/NN
by/IN
inhibition/NN
of/IN
specific/JJ
transcriptional/JJ
regulatory/JJ
proteins/NNS
is/VBZ
necessary/JJ
for/IN
determining/VBG
how/WRB
these/DT
factors/NNS
participate/VBP
in/IN
cellular/JJ
differentiation/NN
./.
=====
The/DT
functions/NNS
of/IN
these/DT
proteins/NNS
can/MD
be/VB
antagonized/VBN
by/IN
several/JJ
methods/NNS
,/,
each/DT
with/IN
specific/JJ
limitations/NNS
./.
=====
Inhibition/NN
of/IN
sequence-specific/JJ
DNA-binding/JJ
proteins/NNS
was/VBD
achieved/VBN
with/IN
double-stranded/JJ
(/(
ds/JJ
)/)
phosphorothioate/NN
oligonucleotides/NNS
that/WDT
contained/VBD
octamer/NN
or/CC
kappa/NN
B/NN
consensus/NN
sequences/NNS
./.
=====
The/DT
phosphorothioate/NN
oligonucleotides/NNS
specifically/RB
bound/VBD
either/CC
octamer/NN
transcription/NN
factor/NN
or/CC
nuclear/JJ
factor/NN
(/(
NF/NN
)/)
-kappa/NN
B/NN
./.
=====
The/DT
modified/VBN
oligonucleotides/NNS
accumulated/VBD
in/IN
cells/NNS
more/RBR
effectively/RB
than/IN
standard/JJ
ds/JJ
oligonucleotides/NNS
and/CC
modulated/VBD
gene/NN
expression/NN
in/IN
a/DT
specific/JJ
manner/NN
./.
=====
Octamer-dependent/JJ
activation/NN
of/IN
a/DT
reporter/NN
plasmid/NN
or/CC
NF-kappa/NN
B-dependent/JJ
activation/NN
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
(/(
HIV/NN
)/)
enhancer/NN
was/VBD
inhibited/VBN
when/WRB
the/DT
appropriate/JJ
phosphorothioate/NN
oligonucleotide/NN
was/VBD
added/VBN
to/TO
a/DT
transiently/RB
transfected/VBN
B/NN
cell/NN
line/NN
./.
=====
Addition/NN
of/IN
phosphorothioate/NN
oligonucleotides/NNS
that/WDT
contained/VBD
the/DT
octamer/NN
consensus/NN
to/TO
Jurkat/NN
T/NN
leukemia/NN
cells/NNS
inhibited/VBD
interleukin-2/NN
(/(
IL-2/NN
)/)
secretion/NN
to/TO
a/DT
degree/NN
similar/JJ
to/TO
that/DT
observed/VBN
with/IN
a/DT
mutated/VBN
octamer/NN
site/NN
in/IN
the/DT
IL-2/NN
enhancer/NN
./.
=====
The/DT
ds/JJ
phosphorothioate/NN
oligonucleotides/NNS
probably/RB
compete/VBP
for/IN
binding/NN
of/IN
specific/JJ
transcription/NN
factors/NNS
and/CC
may/MD
provide/VB
anti-viral/JJ
,/,
immunosuppressive/JJ
,/,
or/CC
other/JJ
therapeutic/JJ
effects/NNS
./.